Gregory Philip D
Chief Scientific Officer at TSVT; Chief Scientific Officer at BLUE; SVP of Research & CSO at SGMO
- Sold, on record
- $16.8M
- Dollars the filings state
- Form 4 sales
- 119
- Latest Jan 5, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TSVTPlan not statedJul 15 2022
Sold 2,365 shares at $13.81 ($33k)
Gregory Philip D, Chief Scientific Officer
Sold 2.2% of holdings ($1.5M position)106,795 shares leftFiling
- 2 Form 4 sale TSVTPlan not statedAug 5 +21 days
Sold 2,407 shares at $16.23 ($39k)
Gregory Philip D, Chief Scientific Officer
Sold 2.3% of holdings ($1.7M position)104,388 shares leftFiling
- 3 Form 4 sale TSVTPlan not statedJan 9 +157 days
Sold 3,794 shares at $10.33 ($39k)
Gregory Philip D, Chief Scientific Officer
Sold 3.6% of holdings ($1.1M position)100,594 shares left1.6x usual sizeFiling
- 4 Form 4 sale TSVTPlan not statedJan 11 +2 days
Sold 1,076 shares at $10.63 ($11k)
Gregory Philip D, Chief Scientific Officer
Sold 1.1% of holdings ($1.1M position)99,518 shares left0.5x usual sizeFiling
- 5 Form 4 sale TSVTRoutineAug 3 +204 days
Sold 3,966 shares at $6.13 ($24k)
Gregory Philip D, Chief Scientific Officer
10b5-1 planSold 1.5% of holdings ($1.6M position)263,409 shares left1.7x usual sizeFiling
- 6 Form 4 sale TSVTRoutineAug 22 +19 days
Sold 6,159 shares at $5.49 ($34k)
Gregory Philip D, Chief Scientific Officer
10b5-1 planSold 2.3% of holdings ($1.4M position)257,250 shares left2.6x usual sizeFiling
- 7 Form 4 sale TSVTUnusualJan 3 +134 days
Sold 25,613 shares at $3.87 ($99k)
Gregory Philip D, Chief Scientific Officer
No 10b5-1 planSold 10% of holdings ($996k position)231,637 shares left10.6x usual sizeFiling
- 8 Form 4 sale TSVTNo planJan 5 +2 days
Sold 795 shares at $3.75 ($3k)
Gregory Philip D, Chief Scientific Officer
No 10b5-1 planSold 0.3% of holdings ($869k position)230,842 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (119)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | TSVT | Chief Scientific Officer | Form 4 sale | 795 | $3k | 0.3% | No plan | SEC |
| Jan 3, 2024 | TSVT | Chief Scientific Officer | Form 4 sale | 25,613 | $99k | 10.0% | Unusual | SEC |
| Aug 22, 2023 | TSVT | Chief Scientific Officer | Form 4 sale | 6,159 | $34k | 2.3% | Routine | SEC |
| Aug 3, 2023 | TSVT | Chief Scientific Officer | Form 4 sale | 3,966 | $24k | 1.5% | Routine | SEC |
| Jan 11, 2023 | TSVT | Chief Scientific Officer | Form 4 sale | 1,076 | $11k | 1.1% | Plan not stated | SEC |
| Jan 9, 2023 | TSVT | Chief Scientific Officer | Form 4 sale | 3,794 | $39k | 3.6% | Plan not stated | SEC |
| Aug 5, 2022 | TSVT | Chief Scientific Officer | Form 4 sale | 2,407 | $39k | 2.3% | Plan not stated | SEC |
| Jul 15, 2022 | TSVT | Chief Scientific Officer | Form 4 sale | 2,365 | $33k | 2.2% | Plan not stated | SEC |
| Jan 7, 2022 | TSVT | Chief Scientific Officer | Form 4 sale | 1,452 | $35k | 2.3% | Plan not stated | SEC |
| May 3, 2021 | BLUE | Chief Scientific Officer | Form 4 sale | 39 | $1k | 0.1% | Plan not stated | SEC |
| Apr 5, 2021 | BLUE | Chief Scientific Officer | Form 4 sale | 39 | $1k | 0.1% | Plan not stated | SEC |
| Mar 2, 2021 | BLUE | Chief Scientific Officer | Form 4 sale | 39 | $1k | 0.1% | Plan not stated | SEC |
| Feb 17, 2021 | BLUE | Chief Scientific Officer | Form 4 sale | 664 | $19k | 1.4% | Plan not stated | SEC |
| Feb 2, 2021 | BLUE | Chief Scientific Officer | Form 4 sale | 59 | $3k | 0.2% | Plan not stated | SEC |
| Jan 6, 2021 | BLUE | Chief Scientific Officer | Form 4 sale | 2,799 | $126k | 7.8% | Unusual | SEC |
| Dec 2, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 59 | $3k | 0.2% | Plan not stated | SEC |
| Nov 2, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 59 | $3k | 0.2% | Plan not stated | SEC |
| Oct 2, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 60 | $3k | 0.2% | Plan not stated | SEC |
| Sep 3, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 58 | $3k | 0.2% | Plan not stated | SEC |
| Aug 3, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 59 | $4k | 0.2% | Plan not stated | SEC |
| Jul 2, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 59 | $4k | 0.2% | Plan not stated | SEC |
| Jun 2, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 59 | $4k | 0.2% | Plan not stated | SEC |
| Jan 10, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 600 | $56k | 2.4% | Plan not stated | SEC |
| Jan 7, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 4,134 | $372k | 14.3% | Plan not stated | SEC |
| Jan 6, 2020 | BLUE | Chief Scientific Officer | Form 4 sale | 250 | $22k | 0.9% | Plan not stated | SEC |
| Dec 17, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $170k | 5.8% | Plan not stated | SEC |
| Dec 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 250 | $20k | 0.9% | Plan not stated | SEC |
| Nov 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 250 | $20k | 0.8% | Plan not stated | SEC |
| Oct 7, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 250 | $22k | 0.8% | Plan not stated | SEC |
| Sep 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 850 | $86k | 2.8% | Plan not stated | SEC |
| Aug 8, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 950 | $118k | 3.1% | Plan not stated | SEC |
| Aug 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 850 | $99k | 2.7% | Plan not stated | SEC |
| Jul 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $232k | 5.6% | Plan not stated | SEC |
| Jun 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $231k | 5.5% | Plan not stated | SEC |
| May 6, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $249k | 5.4% | Plan not stated | SEC |
| Apr 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $284k | 5.3% | Plan not stated | SEC |
| Mar 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $266k | 5.2% | Plan not stated | SEC |
| Feb 5, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $248k | 5.2% | Plan not stated | SEC |
| Jan 16, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 1,900 | $236k | 6.6% | Plan not stated | SEC |
| Jan 7, 2019 | BLUE | Chief Scientific Officer | Form 4 sale | 3,879 | $436k | 12.4% | Plan not stated | SEC |
| Dec 6, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 850 | $91k | 2.7% | Plan not stated | SEC |
| Nov 5, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $247k | 5.5% | Plan not stated | SEC |
| Oct 5, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $253k | 5.4% | Plan not stated | SEC |
| Sep 5, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $293k | 5.3% | Plan not stated | SEC |
| Aug 6, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 1,800 | $282k | 5.3% | Plan not stated | SEC |
| Jun 18, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 3,901 | $696k | 13.3% | Plan not stated | SEC |
| Apr 2, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $380k | 7.1% | Plan not stated | SEC |
| Mar 1, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $450k | 6.9% | Plan not stated | SEC |
| Feb 1, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $461k | 6.7% | Plan not stated | SEC |
| Jan 5, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 1,712 | $297k | 6.7% | Plan not stated | SEC |
| Jan 3, 2018 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $407k | 8.1% | Plan not stated | SEC |
| Dec 1, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $388k | 7.8% | Plan not stated | SEC |
| Nov 1, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $325k | 7.6% | Plan not stated | SEC |
| Oct 2, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $297k | 7.3% | Plan not stated | SEC |
| Sep 1, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $284k | 7.1% | Plan not stated | SEC |
| Aug 7, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 750 | $74k | 2.4% | Plan not stated | SEC |
| Aug 1, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 1,500 | $140k | 4.7% | Plan not stated | SEC |
| Jul 6, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 2,250 | $234k | 6.7% | Plan not stated | SEC |
| Jun 16, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 3,295 | $360k | 9.2% | Plan not stated | SEC |
| Jun 6, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 1,500 | $149k | 4.0% | Plan not stated | SEC |
| Jun 1, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 1,500 | $113k | 4.0% | Plan not stated | SEC |
| May 1, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 1,500 | $132k | 3.9% | Plan not stated | SEC |
| Jan 5, 2017 | BLUE | Chief Scientific Officer | Form 4 sale | 790 | $53k | 2.6% | Plan not stated | SEC |
| Jun 16, 2016 | BLUE | Chief Scientific Officer | Form 4 sale | 2,931 | $116k | 8.9% | Plan not stated | SEC |
| Jun 1, 2015 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $186k | 11.4% | Plan not stated | SEC |
| May 1, 2015 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $189k | 11.4% | Plan not stated | SEC |
| Apr 1, 2015 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $227k | 11.4% | Plan not stated | SEC |
| Mar 2, 2015 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $259k | 11.4% | Plan not stated | SEC |
| Feb 2, 2015 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $193k | 11.4% | Plan not stated | SEC |
| Jan 2, 2015 | SGMO | SVP, Research & CSO | Form 4 sale | 15,000 | $237k | 11.4% | Plan not stated | SEC |
| Dec 1, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $175k | 12.1% | Plan not stated | SEC |
| Nov 3, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $179k | 12.1% | Plan not stated | SEC |
| Oct 1, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $162k | 12.1% | Plan not stated | SEC |
| Sep 2, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $202k | 12.1% | Plan not stated | SEC |
| Aug 1, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $188k | 12.1% | Plan not stated | SEC |
| Jul 1, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $235k | 12.1% | Plan not stated | SEC |
| Jun 2, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $193k | 12.1% | Plan not stated | SEC |
| May 1, 2014 | SGMO | SVP of Research & CSO | Form 4 sale | 15,000 | $205k | 12.1% | Plan not stated | SEC |
| Apr 1, 2014 | SGMO | Sr. VP Res. & CSO | Form 4 sale | 15,000 | $267k | 12.1% | Plan not stated | SEC |
| Mar 21, 2014 | SGMO | Officer | Form 4 sale | 15,000 | $336k | 12.1% | Plan not stated | SEC |
| Feb 3, 2014 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $282k | 12.1% | Plan not stated | SEC |
| Jan 2, 2014 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $203k | 12.1% | Plan not stated | SEC |
| Dec 2, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $175k | 14.3% | Plan not stated | SEC |
| Nov 5, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $144k | 14.3% | Plan not stated | SEC |
| Oct 1, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $158k | 14.3% | Plan not stated | SEC |
| Sep 3, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $155k | 14.3% | Plan not stated | SEC |
| Aug 1, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $148k | 14.3% | Plan not stated | SEC |
| Jul 29, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 15,000 | $151k | 14.3% | Plan not stated | SEC |
| Jun 3, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 3,000 | $24k | 3.2% | Plan not stated | SEC |
| May 1, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 6,000 | $61k | 6.3% | Plan not stated | SEC |
| Apr 1, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 6,000 | $57k | 6.3% | Plan not stated | SEC |
| Mar 1, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 6,000 | $60k | 6.3% | Plan not stated | SEC |
| Feb 1, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 6,000 | $57k | 6.3% | Plan not stated | SEC |
| Jan 2, 2013 | SGMO | Vice President, Research & CSO | Form 4 sale | 6,000 | $36k | 6.3% | Plan not stated | SEC |
| Dec 10, 2012 | SGMO | Vice President, Research & CSO | Form 4 sale | 12,000 | $72k | 11.8% | Plan not stated | SEC |
| Oct 17, 2012 | SGMO | VP, Therapeutic Dev. & CMO | Form 4 sale | 6,000 | $36k | 10.7% | Plan not stated | SEC |
| Sep 9, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 2,500 | $15k | 100.0% | Unusual | SEC |
| Jul 1, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 15,000 | $90k | 100.0% | Unusual | SEC |
| Jun 1, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 15,000 | $102k | 100.0% | Unusual | SEC |
| May 2, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 15,000 | $110k | 100.0% | Unusual | SEC |
| Apr 25, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 19,433 | $147k | 100.0% | Unusual | SEC |
| Mar 1, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 5,000 | $43k | 53.0% | Unusual | SEC |
| Feb 1, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 2,500 | $20k | 21.0% | Plan not stated | SEC |
| Jan 3, 2011 | SGMO | CSO & Vice President, Research | Form 4 sale | 2,500 | $17k | 17.3% | Plan not stated | SEC |
| Dec 8, 2010 | SGMO | CSO & Vice President, Research | Form 4 sale | 2,500 | $15k | 16.7% | Plan not stated | SEC |
| May 3, 2010 | SGMO | CSO & Vice President, Research | Form 4 sale | 2,500 | $16k | 14.3% | Plan not stated | SEC |
| Apr 14, 2010 | SGMO | CSO & Vice President, Research | Form 4 sale | 2,500 | $15k | 12.5% | Plan not stated | SEC |
| Sep 2, 2008 | SGMO | Vice President, Research | Form 4 sale | 1,000 | $10k | 100.0% | Unusual | SEC |
| Aug 15, 2008 | SGMO | Vice President, Research | Form 4 sale | 10,000 | $106k | 33.4% | Unusual | SEC |
| Aug 1, 2008 | SGMO | Vice President, Research | Form 4 sale | 1,000 | $11k | 100.0% | Unusual | SEC |
| Jul 1, 2008 | SGMO | Vice President, Research | Form 4 sale | 1,000 | $10k | 100.0% | Unusual | SEC |
| Jun 2, 2008 | SGMO | Vice President, Research | Form 4 sale | 1,000 | $11k | 100.0% | Unusual | SEC |
| May 1, 2008 | SGMO | Vice President, Research | Form 4 sale | 1,000 | $13k | 100.0% | Unusual | SEC |
| Apr 1, 2008 | SGMO | Vice President, Research | Form 4 sale | 1,000 | $10k | 100.0% | Unusual | SEC |
| Mar 19, 2008 | SGMO | Vice President, Research | Form 4 sale | 1,000 | $10k | 100.0% | Unusual | SEC |
| Dec 6, 2007 | SGMO | Vice President, Research | Form 4 sale | 5,000 | $80k | 100.0% | Unusual | SEC |
| Nov 8, 2007 | SGMO | Vice President, Research | Form 4 sale | 25,000 | $439k | 100.0% | Unusual | SEC |
| Feb 13, 2007 | SGMO | Vice President, Research | Form 4 sale | 8,000 | $65k | 66.7% | Unusual | SEC |
| Jun 2, 2006 | SGMO | Vice President, Research | Form 4 sale | 6,000 | $45k | 60.0% | Unusual | SEC |